Clinical Trials Logo

Filter by:
NCT ID: NCT04867941 Completed - Clinical trials for Hepatic Insufficiency

A Study to Evaluate the Effect of Hepatic Insufficiency on the Pharmacokinetics (PK) of ACP-196

Start date: October 21, 2014
Phase: Phase 1
Study type: Interventional

The study will evaluate the influence of hepatic insufficiency on the PK of ACP-196.

NCT ID: NCT04867902 Completed - Bariatric Surgery Clinical Trials

Gaining Optimism After Weight Loss Surgery (GOALS) I

GOALS
Start date: June 29, 2021
Phase: N/A
Study type: Interventional

This study examines the feasibility, acceptability, and preliminary impact of an adapted positive psychology-motivational interviewing (PP-MI) intervention for physical activity among patients who have recently undergone bariatric surgery.

NCT ID: NCT04867876 Completed - Quality of Life Clinical Trials

Qol Following Management for Pediatric UI

Start date: May 2014
Phase: N/A
Study type: Interventional

A comparison of changes between symptoms of incontinence and pediatric quality of life will be used to draw conclusions about whether differences in quality of life are noted with changes in symptoms of incontinence.

NCT ID: NCT04867850 Completed - Cancer Clinical Trials

Effect of Behavioral Nudges on Serious Illness Conversation Documentation

SPP2
Start date: September 9, 2021
Phase: N/A
Study type: Interventional

The main purpose of this research study is to evaluate the effectiveness of "nudges" to clinicians, to patients, or to both in increasing Serious Illness Conversation (SIC) documentation; and to identify moderators of implementation effects on SIC documentation. The investigators will employ rapid-cycle approaches to optimize the framing of nudges to clinicians and patients prior to initiating the trial and mixed methods to explore contextual factors and mechanisms. The investigators will conduct a four-arm pragmatic cluster randomize clinical trial to test the effectiveness of nudges to clinicians, nudges to patients, or nudges to both in increasing the frequency and timeliness of SIC documentation in cancer patients vs. usual care (UC). The investigators hypothesize that each of the implementation strategy arms will significantly increase SIC documentation compared to UC and that the combination of nudges to clinicians and to patients will be the most effective.

NCT ID: NCT04867785 Completed - Type 2 Diabetes Clinical Trials

A Study of LY3437943 in Participants With Type 2 Diabetes

Start date: May 13, 2021
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to evaluate the efficacy and safety of LY3437943 in participants with type 2 diabetes (T2D) who failed to achieve adequate glycemic control on diet and exercise alone or on a stable dose of metformin. This study will last about 43 weeks.

NCT ID: NCT04867733 Completed - Healthy Clinical Trials

Visualizing Dermal Micropores With OCT

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The study to be performed will allow visualization of skin micropores following microneedle treatment in healthy subjects in differing racial/ethnic backgrounds.

NCT ID: NCT04867603 Completed - Prostate Cancer Clinical Trials

Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions

Start date: June 29, 2021
Phase:
Study type: Observational

The purpose of this study is to evaluate a radioactive diagnostic study drug, which is called Gallium-68 Prostate Specific Membrane Antigen ([Ga-68]PSMA) for characterization of prostate abnormalities.

NCT ID: NCT04867473 Completed - Lyme Disease Clinical Trials

Feasibility of Teleyoga for Treatment of Lyme Disease

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

Primary Aims: Modify an existing teleyoga intervention to use with Lyme disease (LD) patients and address the technical challenges of at-home teleyoga

NCT ID: NCT04867434 Completed - Submental Fat Clinical Trials

Efficacy and Safety of RZL-012 on Submental Fat Reduction

Start date: June 15, 2021
Phase: Phase 2
Study type: Interventional

A total of 135 eligible male or female subjects will be randomized according to a predetermined randomization scheme (1:1:1 ratio) to receive a single multi-injection treatment of high dose RZL-012, low dose RZL-012, or placebo on Day 0. They will be monitored for safety and efficacy over 84 days.

NCT ID: NCT04867382 Completed - Opioid-use Disorder Clinical Trials

Comparing Two Training Methods for Opioid Wizard

Start date: April 9, 2021
Phase: N/A
Study type: Interventional

The prevalence of opioid use disorder (OUD) and opioid-related deaths has risen dramatically in recent years. Effective treatments, including medications for opioid use disorder (MOUDs; e.g., buprenorphine-naloxone and methadone) are under-utilized. There are few evidence-based interventions for changing attitudes toward Opioid Use Disorder (OUD) in the general public and especially among healthcare clinicians. This study proposed an innovative intervention to change attitudes of Primary Care Clinicians (PCCs) toward persons with OUD. Study participants were stratified into one of two online learning courses: the intervention training was compared with an attention-control training.